HistoSonics, a company founded by biomedical engineer Zhen Xu in 2009, is developing a technique called histotripsy to target different types of cancer. Xu has been refining the approach for years in an effort to treat tumor cells without the need for incisions or other potentially invasive procedures.

Read Entire Article